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Abstract
Adenylyl cyclase (AC) is an important messenger involved in G-protein-coupled-receptor
signal transduction pathways, which is a well-known target for drug development. AC is reg-
ulated by activated stimulatory (Gαs) and inhibitory (Gαi) G proteins in the cytosol. Although
experimental studies have shown that these Gα subunits can stimulate or inhibit AC’s func-
tion in a non-competitive way, it is not well understood what the difference is in their mode of
action as both Gα subunits appear structurally very similar in a non-lipidated state. However,
a significant difference between Gαs and Gαi is that while Gαs does not require any lipidation
in order to stimulate AC, N-terminal myristoylation is crucial for Gαi’s inhibitory function as
AC is not inhibited by non-myristoylated Gαi. At present, only the conformation of the com-
plex including Gαs and AC has been resolved via X-ray crystallography. Therefore, under-
standing the interaction between Gαi and AC is important as it will provide more insight into
the unknown mechanism of AC regulation. This study demonstrates via classical molecular
dynamics simulations that the myristoylated Gαi1 structure is able to interact with apo adeny-
lyl cyclase type 5 in a way that causes inhibition of the catalytic function of the enzyme, sug-
gesting that Gα lipidation could play a crucial role in AC regulation and in regulating G
protein function by affecting Gαi’s active conformation.
Author summary
Communication between cells is essential for the survival of any multicellular organism.
When these mechanisms cannot function properly, diseases can occur such as heart fail-
ure or Parkinson’s disease. Understanding cell communication is therefore crucial for
drug development. Important proteins in cellular signalling are the ones that initiate
mechanisms in the cell after the signal of an extracellular trigger is transported from out-
side to inside the cell. G proteins (GPs) are an example of such proteins. Experimental
studies have shown that GPs can perform stimulatory or inhibitory functions, however, it
is not well understood what the difference is in their mode of action, especially as they are
structurally very similar. Adenylyl cyclase (AC) is an enzyme which can be stimulated or
inhibited by GPs, depending on which type of GP is active. Hence, AC is a good candidate
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for investigating the difference in function between GPs. However, only the structure of
the stimulatory GP interacting with AC is known. Here, we investigate for the first time
the effect of the interaction of an inhibitory GP with AC via classical molecular dynamics
simulations in order to obtain a better understanding of the difference between stimula-
tory and inhibitory GP association and AC regulation.
Introduction
Many proteins are involved in cell communication of which one type is the G-protein-coupled
receptor (GPCR), embedded in the membrane. GPCRs are part of a major signalling pathway,
the GPCR signal transduction pathway, which enables the transfer of a signal from the extra-
cellular region to the intracellular side and is a key target for drug development. A large diver-
sity of GPCRs can be found in nature as about 800 human genes are involved in storing
different types of GPCRs that can interact with neurotransmitters, hormones or exogenous
ligands, for example [1].
In the cytosol, G proteins, composed of an α, β and γ subunit, are the first interaction part-
ner of activated GPCRs. When a heterotrimeric G protein is activated by a GPCR, the trimer
dissociates, resulting in an α subunit and a βγ dimer [2]. Activated Gα subunits transport the
signal from the membrane to other regions of the cell by stimulating or inhibiting reactions via
protein-protein interactions. Besides direct activation by GPCRs, the function of G proteins
can also be influenced by other environmental factors, such as lipidation. Permanent N-myris-
toylation, for instance, is known to change the structure and function of the inhibitory G-pro-
tein subunit Gαi1 in its active GTP-bound state [3–6].
While a wide range of GPCRs exists, a relatively low diversity is present in the G protein
family, e.g. in the human body. The human body includes only a relatively small variety of 21
α, 6 β and 12 γ subunits [1]. The Gα subunits are divided into four major subfamilies based
on their sequence homology and function [7]: stimulatory Gαs, inhibitory Gαi, Gαq and Gα12
[8, 9]. Overall the structures of the Gα subfamilies are similar (S1 Fig, Fig 1), including a Ras
domain and an alpha helical (AH) domain. The Ras domain is present in all members of the
G-protein superfamily and can perform hydrolysis of GTP to GDP during deactivation of the
Gα subunit [10]. In addition, the domain includes an interaction site for GPCRs as well as
regions that can interact with the βγ dimer. Moreover, the Ras domain can also undergo lipida-
tion. Except for Gαt, all Gα proteins are able to reversibly bind a palmitate to their N-terminal
helix. Besides palmitoylation, Gαi can also permanently bind a myristoyl moiety to the N-ter-
minus that appears to be crucial for the function of the subunit (Fig 1C) [4, 5, 9, 11].
The AH domain is unique to the Gα subfamilies, which is composed of six α helices and
interacts with the Ras domain when GTP or GDP is present (Fig 1C). However, this interac-
tion between the AH and Ras domain is weakened when a nucleotide is absent in Gα’s active
site [12–14]. The high structural similarity among members of the Gα subfamilies is illustrated
by aligning the X-ray structures of stimulatory Gαs and inhibitory Gαi1, resulting in a root
mean square deviation (RMSD) of only 1.07 Å between the Cα atoms of the two structures
(Fig 1A) [15, 16]. Hence, from a comparison of the structures it is difficult to conclude what
the origin is of their inverse action, i.e., how the structure can be related to a stimulatory
respectively an inhibitory effect.
An example of a protein in which both Gαi and Gαs are important for regulation is adenylyl
cyclase (AC). Ten isoforms of AC are known of which nine are membrane-bound (AC1-9)
and one is soluble (sAC) [17]. These different types of AC are found throughout the body in
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Fig 1. Differences and similarities of Gα:AC complexes and activated Gα subunit structures. (A) Structural alignment of GTP-analog-bound
Gαi1 (PDB code 1AZT) in cyan and GTP-analog-bound Gαs (PDB code 1AS0) in grey. (B) View of the Gαs:AC complex (PDB code 1AZS) from the
cytosolic side. The Gαs subunit is depicted in grey, while the C1 domain is represented in blue and the C2 domain is shown in red. The location of the
Gαi1 structure is described by the cyan star. (C) View of the docked Gαi1myr:AC5 complex from the cytosolic side. The Gαi1myr subunit is depicted in
cyan with the myristoyl moiety shown in yellow and the GTP molecule in orange. The C1 domain is represented in blue and the C2 domain is shown in
red. The location of the Gαs structure is described by the grey star.
https://doi.org/10.1371/journal.pcbi.1005673.g001
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different concentrations. AC5, for instance, is present in high quantities in the brain, the spinal
cord and the heart, and is associated to congestive heart failure and pain perception [18, 19].
G proteins have the ability to either stimulate (Gs) or inhibit (Gi) adenylyl cyclases’ conversion
of adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP) and pyrophos-
phate [20, 21].
ACs consist of two membrane-bound regions, each built from six trans-membrane
domains, and a catalytic region in the cytosol that includes two pseudo-symmetric domains,
C1 and C2 (Fig 1) [22]. GTP-bound Gαs is known to bind to the C2 domain for which the
interaction site is known from X-ray structures of Gαs interacting with AC (Fig 1B) [23]. Such
data is absent for the case of Gαi. In the absence of direct experimental information, a putative
interaction site of GTP-bound Gαi has been suggested in analogy to the known structure of
the complex of Gαs and AC (Gαs:AC) as the pseudo-symmetric site on the C1 domain
(Fig 1B). However, how the interaction of Gαi on the C1 domain should induce inhibition is
not obvious [5]. Furthermore, since with this hypothesis the interaction sites of Gαi1 and Gαs
are highly similar in addition to their structures, it is unclear how the α subunits can differenti-
ate the two binding sites on AC and what the cause is of the stimulatory versus the inhibitory
effect induced by the subunits.
A factor that could play an important role in differentiating the action of Gαi and Gαs is the
difference in lipidation of both subunits. Although the X-ray structures in the Protein Data
Base (PDB) [24] of the active inhibitory and stimulatory Gα subunits tightly align, the N-ter-
minus, which is not resolved for Gαi or Gαs, is not myristoylated during the expression process
of Gαi as lipidation can hinder crystallisation [4]. Hence, it is not clear to what extent the miss-
ing N-terminal myristoyl moiety affects the Gαi structure of the remaining protein while the
bound myristoyl group has been known to be crucial for Gαi’s conformation and function as
the ability to interact with AC5 is abolished upon removal of the myristate [4–6]. Classical
molecular dynamics (MD) simulations of myristoylated GTP-bound Gαi1, Gαi1
myr, demon-
strate the stability of the myristoyl moiety on the Ras domain due to a hydrophobic pocket
formed by β2-β3, α1 and the C-terminus α5 (Fig 1C) and show that myristoylation can have a
significant effect on the conformation of the subunit [25]. The findings suggest the possibility
of an alternative novel interaction mode and open up new possibilities for selective interac-
tions with AC. This is because the found structural changes in the classical MD simulations
of Gαi1
myr [25] suggest that the subunit will not be able to interact with C1 as Gαs interacts
with C2.
Here, we investigate the interaction between Gαi1
myr and AC, using classical MD simula-
tions. To this end, the initial structure of Gαi1
myr was taken from reference [25] in which a 2 μs
classical MD simulation of Gαi1
myr is described. Gαi1
myr can inhibit only particular isoforms
of AC: AC1, AC5, AC6 [26]. In this study AC5 is used because X-ray structures of AC’s cata-
lytic domains are composed of isoforms AC2 and AC5. Ca. 16 AC structures can be found in
the PDB with different resolutions and/or crystallisation conditions. All available structures
have been co-crystallised with a Gαs subunit and correspond therefore to stimulated confor-
mations at various levels of activation, depending on the nature of bound cofactors (e.g.
cofactor-free complex of AC, substrate-bound AC complex).
When AC5 becomes active, roughly three conformational options are possible: a complex
of Gαs and AC5, Gαs:AC5, Gαs in complex with ATP-bound AC5, Gαs:AC5(ATP), or a
complex of Gαs and AC5 bound to the reaction products cAMP and pyrophosphate,
Gαs:AC5(cAMP). Currently, it is not known which one of these forms is most likely to interact
with Gαi1
myr, or if Gαi1
myr can inhibit all of them. In this study, the structure of the AC5 pro-
tein was taken from a crystal structure of the cofactor-free Gαs:AC5 complex. This apo AC5
structure was used as it could provide insight into Gαi1
myr’s inhibitory effect on a stimulated
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conformation of AC5 in the absence of ATP. The selected AC5 structure was employed to
build a Gαi1
myr:AC5 complex (Fig 1C) and to explore if the binding of Gαi1
myr is able to affect
the active conformation initially induced by Gαs. The absence of ATP in the active site pro-
vides the opportunity to investigate Gαi1
myr’s ability to prevent the formation of AC’s fully acti-
vated form by altering AC’s conformation unfavourably prior to substrate association. In
order to verify which changes are due to the interaction of AC5 with Gαi1
myr and which alter-
ations are a result of the removal of Gαs, a second simulation of AC5, with the Gαs subunit
removed, was performed on the same time scale as the Gαi1
myr:AC5 complex.
Hence, in this study the impact of the presence of myristoylated Gαi on the function of AC5
is explored via investigating the conformational features of the Gαi1
myr:AC5 and the free AC5
complex (a system that only includes AC’s catalytic region in solution) in comparison with the
Gαs:AC X-ray structure. The Gαi1
myr:AC5 complex has been obtained via docking the Gαi1
myr
structure on to the C1 domain of AC5. Already the initial docking results confirm the possible
importance of the myristoyl-induced structural changes of Gαi1
myr as a new interaction mode
for Gαi1
myr could be identified. The comparison of the performed classical MD simulation
(2.5 μs) of the Gαi1myr:AC5 complex and the free AC5 system suggest two possible ways of AC
inhibition in its apo form. First, Gαi1
myr seems to inhibit AC’s conversion of ATP to cAMP by
preventing active-site formation as the Gαi1
myr subunit perturbs the conformation of the active
site at the C1/C2 interface. Second, the effect of Gαi1
myr on the AC structure leads to a closed
conformation of the Gαs binding site on C2, decreasing the probability of Gαs association and
thus of a counter-balancing re-stimulation of the AC5 activity. Taken together, the observed
events lead to a suggestion for a putative Gαi1
myr inhibition mechanism of apo AC5 in which
lipidation is crucial for Gαi1
myr’s function and its protein-protein interactions. Hence, the
results of this study provide a possible indication that lipidation could play a significant role in
regulating G protein function and therefore could impact signal transduction in G protein
mediated pathways [4–6].
Materials and methods
Initial structures
The PDB structure 1AZS, including the Gαs:AC complex with AC in the apo form, was used
as a template, including 1AZS’s C1 and C2 domain, for the initial AC5 structure of Rattus nor-
vegicus (UniprotKB Q04400) [27–29]. The structure of the Rattus norvegicus Gαi1
myr subunit
(UniprotKB P10824) interacting with GTP and Mg2+ was taken from reference [25] (S2 and
S3 Figs).
Docking of Gαi1myr on AC5
The HADDOCK web server [30] was used for docking ten conformations of Gαi1
myr on the
catalytic domains of AC5 of Rattus norvegicus. The Gαi1
myr snapshots were extracted at the
end of the Gαi1
myr classical MD trajectory (around 1.9 μs) discussed in reference [25], with a
time interval of 0.5 ns. The active region of Gαi1 was defined in HADDOCK as a large part of
the AH domain (112-167), the switch I region (175-189) and the switch II region (200-220),
allowing for a large unbiased area on the Gαi1
myr protein surface to be taken into account dur-
ing docking. The active region of AC5’s C1 domain was defined as the α1 helix (479-490) and
the C-terminal region of the α3 helix (554-561) because experimentally it has been found that
Gαi1
myr is unable to interact with C2 and its main interactions with AC are with the C1
domain [5]. Passive residues, residues that could take part in protein-protein interaction, were
defined as residues around the active residues that are on the protein surface and within a
radius of 6.5 Å of any active residue [30].
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The initial Gαi1
myr:AC5 complex for the classical MD simulations was selected based on (1)
the absence of overlap between the C2 domain and Gαi1
myr, (2) no overlap with Gαi1
myr’s GTP
binding region and the interaction site of Gαi1
myr with C1 and (3) presence of similar com-
plexes in the top-ten docking results of the docking calculations performed for all ten Gαi1
myr
snapshots. The first property of the selection criteria is important since Gαi1
myr is unable to
interact with C2 [5]. The second criterium has been defined since GTP is located in the active
site of Gαi1
myr in the classical MD simulations, but was not incorporated in the docking proce-
dure because this is not possible in HADDOCK. Therefore, no overlap between the GTP bind-
ing site and the C1 domain should be present in the docking result as otherwise the GTP
molecule will not be able to fit in Gαi1
myr’s active site. The last criterium is the presence of sim-
ilar Gαi1
myr:AC5 complexes of the selected complex in all top-ten docking results which
increases the probability that complexation of the two proteins is not conformation specific,
but is robust as similar complexes can be obtained using different conformations of Gαi1
myr.
Classical molecular dynamics simulations
The Gαi1
myr:AC5 complex was used to simulate the protein complex for 2.5 μs at 310 K and 1
bar using a Nose´-Hoover thermostat and an isotropic Parrinello-Rahman barostat. In the
active site of Gαi1
myr one Mg2+ ion and a GTP molecule are present. In order to closer mimic
an AC5 system with which ATP or a product such as pyrophosphate would be able to interact,
a Mg2+ ion was added to the active site of AC5 (see S1 Appendix). Additionally, about 68 000
water molecules and 150 mM KCl are present in the simulated system.
The force fields used for the protein and the water molecules are AMBER99SB [31] and
TIP3P [32], which were employed by Gromacs 4.6.6 [33, 34] to perform the runs. For GTP,
the force field generated by Meagher et al. was used [35]. The adjusted force field parameters
for the K+ ions and the Cl- ions were taken from Joung et al. [36]. The Mg2+ ion parameters
originated from Allne´r et al. [37] and the parameter set for the myristoyl group was taken from
reference [25]. The charges for the myristoyl group were obtained with Gaussian 09 [38] based
on Hartree Fock calculations in combination with a 6-31G basis set and using the AMBER
RESP procedure [39]. Appropriate atom types from the AMBER99SB force field were selected
to complete the myristoyl description.
Electrostatic interactions were calculated with the Ewald particle mesh method with a real
space cutoff of 12 Å. Bonds involving hydrogen atoms were constrained using the LINCS algo-
rithm [40]. The time integration step was set to 2 fs.
The free AC5 system was simulated with the same setup as the Gαi1
myr:AC5 complex. The
system was solvated in 30 000 water molecules and a 150 mM KCl concentration. The initial
location of the Mg2+ ion in the active site of the enzyme was the same as in the Gαi1
myr:AC5
complex system.
Structure superpositions and images
Multiprot [41] and VMD [42] were used to align protein structures. Uniprot [43] was used to
align protein sequences. Images were prepared with VMD [42].
Results and discussion
The stability of the docked Gαi1
myr:AC5 complex and the effect of Gαi1
myr association was ver-
ified via investigating the conformational changes in the complex through classical MD simu-
lations on the μs time scale. The X-ray structure used for the initial conformation of AC5 in
the simulated complexes, was co-crystallised with Gαs but is not interacting with substrate or
products from the ATP conversion reaction (see Introduction). Consequently, this
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conformation of AC5 could be viewed as a structure that is present before ATP association,
but is already in an active form, due to its interactions with Gαs. Because of the crystallisation
circumstances used to obtain the selected AC5 structure, the found conformational changes in
the catalytic region of AC5 in the Gαi1
myr:AC5 complex are compared to the conformation
found in the classical MD trajectory of the free AC5 system and the Gαs:AC X-ray structure in
order to verify which structural alterations are due to the presence of Gαi1
myr and which
changes are the result of the absence of Gαs.
Protein-protein interface of the Gαi1myr:AC5 complex
The initial conformation of the Gαi1
myr:AC5 complex suggests that Gαi1
myr’s proposed inter-
action site (see S1 Appendix) affects the conformation of C1 in a different way than Gαs stabi-
lises the C2 domain (Figs 1, 2 and S3 Fig). Unlike Gαs, Gαi1
myr is not located between the
helices of AC5’s catalytic domain, but appears to clamp the C1 domain into its inactive confor-
mation. Gαi1
myr is positioned around AC5’s α3, interacting with α1, α2, and α3 via its switch I,
II and III region together with the C-terminal domain of αB (Fig 2 and S3 Fig). Since C1’s α1
helix appears to decrease its distance with respect to the C2 domain when an ATP analog,
adenosine 5-(α-thio)-triphosphate (ATPαS), is present in the active site (S2 Fig), the interac-
tions between Gαi1
myr and C1’s α1 in the Gαi1
myr:AC5 complex could suggest that one way by
which Gαi1
myr is able to inhibit ATP’s conversion is by preventing C1’s α1 to rearrange upon
ATP binding.
The initial Gαi1
myr conformation is very stable over the entire course of the classical
MD trajectory. Since the starting structure of the Gαi1
myr:AC5 complex is unrelaxed, the
conformation of the Gαi1
myr subunit and the Gαi1
myr/AC5 interface have been investigated
during the MD trajectory to study the stability of the Gαi1
myr:AC5 complex and the effect of
the AC5 interaction on the Gαi1
myr structure. In fact, the structure of Gαi1
myr only changes
minimally by a slight adjustment in the orientation of the alpha helical domain (Fig 2B and
S6 Fig). A striking feature of the interface between Gαi1
myr and C1 is the fact that the switch
regions, I, II and III, remain involved in AC5 binding, as well as the region on the alpha helical
domain that rearranged upon myristoyl binding (Fig 2A and 2B) [25]. Gαi1
myr is stabilised on
AC5 via the C1 domain without major interactions with C2 (Fig 2C). The relative orientation
of Gαi1
myr with respect to the C1 domain stabilises after * 400 ns (S6 Fig). This slight orienta-
tional repositioning is probably a consequence of the relocation of C2’s β7-β8 loop, which
could be due to the removal of the Gαs subunit from the C2 domain in the initial complex
because this β7-β8 loop displacement is present in Gαi1
myr:AC5 as well as in free AC5 (Fig 3).
Besides the orientation of Gαi1
myr, also minor alterations can be observed in Gαi1
myr’s
active site. The interactions of the Mg2+ ion near the GTP binding site (S7 Fig) are moderately
altered compared to the free Gαi1
myr system [25]. In Gαi1
myr:AC5 both of Asp200’s oxygens,
OD1 and OD2, are able to interact with Mg2+, while in free Gαi1
myr only one of Asp200’s oxy-
gens is interacting with the Mg2+ ion [25]. The interaction between Mg2+ and Asp200’s second
oxygen in Gαi1
myr:AC5, OD2, can be temporarily perturbed by a water molecule, which leads
to sudden jumps in the Mg2+ and Asp200OD2 distance (S7 Fig).
Structural effect on AC5’s active site
Gαi1
myr’s interactions with C1 impact the entrance of the ATP binding site. The active
site of AC5 is located at the interface between C1 and C2. Structural changes of both domains
upon Gαi1
myr binding can potentially influence the protein’s activity. When comparing the
root-mean-square deviation of the two domains with respect to AC5’s initial conformation, it
is clear that in the free AC5 as well as in the Gαi1
myr:AC5 complex the C2 domain experiences
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more changes than C1 (Fig 3C). In the X-ray structure (PDB code 1AZS) used as a template to
construct the initial AC5 structure, the C2 domain is interacting with a Gαs subunit. The
removal of Gαs from the C2 domain could affect the RMSD of the domain in the Gαi1
myr:AC5
and free AC5 systems as the initial structure of AC5 is influenced by the presence of Gαs.
During the classical MD runs, the first alteration to C2’s initial structure that can be
observed in both Gαi1
myr:AC5 and free AC5 is the relocation of the β7-β8 loop, positioned on
the cytosolic side (Fig 3). The location of C2’s β7-β8 loop is important for the active conforma-
tion of the active site at the C1/C2 interface (Fig 3 and S2 Fig). Loop relocation and the accom-
panying movement of the two domains appear to have a deactivating effect on the active site
Fig 2. Gαi1myr’s interactions with AC5 are stable over the course of the classical MD trajectory. (A) Aligned structures of the docked model (cyan)
and the Gαi1myr:AC5 complex after * 1.7 μs (orange and red). The structures were aligned on the C1 domain, residues 456 to 644, as this domain’s
RMSD is low over the course of the simulation (Fig 3C). (B) Aligned structures of the docked model (cyan) and the Gαi1myr:AC5 complex after * 1.7 μs
(orange and red). The structures were aligned on the Gαi1myr subunit (residues 34 to 334) in order to show the change in the conformation of Gαi1myr. (C)
Number of hydrogen bonds between Gαi1myr and C1 and Gαi1myr and C2 that are present during the classical MD trajectory.
https://doi.org/10.1371/journal.pcbi.1005673.g002
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(Fig 3 and S2 Fig). For instance, a residue that is known to be part of the active site, Lys1245,
located in the β7-β8 loop, is unable to maintain its orientation towards the ATP binding site
(S8 Fig). A reason for this conformational change in the Gαi1
myr:AC5 and free AC5 simula-
tions could be the absence of Gαs at the C2 domain that destabilises β7-β8’s location. The pres-
ence of Gαi1
myr appears to increase the stability of the β7-β8 loop relocation compared to the
free AC5 system (Fig 3).
An alteration that also occurs around AC5’s active site in the Gαi1
myr:AC5 system is the
decrease in distance between C2’s α4 helix and C1’s β2-β3 loop (Fig 4, S3 Fig). This change in
Fig 3. Change of location of C2’s β7-β8 loop occurs in both Gαi1myr:AC5 and free AC5 systems and a significant difference is observed
between RMSD values of free AC5 and Gαi1myr:AC5 for the C2 domain. (A) Graph of the distances between the Cα atom of Gly1246 (green dot in
image B) and the Cα atoms of Ala483 (red dot in image B) and Asn630 (orange dot in image B). (B) β7-β8 loop’s relocation in the free AC5 system
(purple), the Gαi1myr:AC5 complex (cyan) and PDB structure 1AZS (yellow). The location of the residues used in image A are assigned according to the
Gαi1myr:AC5 structure. (C) Root-mean-square deviations of the backbone of the C1 and the C2 domain. In the RMSD calculation the residues between
463 to 644 were taken into account for the C1 domain and the residues between 1065 to 1135 and 1145 to 1257 were used for the C2 domain.
https://doi.org/10.1371/journal.pcbi.1005673.g003
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the C1/C2 interface appears to make the positioning of ATP in the active site less favourable
because ATP’s adenine moiety, which is positioned between C2’s α4 helix and C1’s β2-β3 loop
when ATP interacts with AC5 (S2 Fig), is unlikely to fit between the C1 and the C2 domain
due to the diminished distance between C1 and C2 compared to the initial AC5 structure.
Although the free AC5 system also undergoes a change in this region, the α4 helix of C2
remains closer to the X-ray location than in the Gαi1
myr:AC5 complex (Fig 4).
In summary, the conformational changes at the C1/C2 interface of Gαi1
myr:AC5 seem to
affect AC5’s active site by interfering with ATP binding. In fact, the new position of the β7-β8
loop can even block the active site entrance, which could prevent ATP entry. The relocation of
C2’s β7-β8 loop, present in the Gαi1
myr:AC5 and the free AC5 systems, could be due to the
removal of Gαs, which interacts with the C2 domain in the template X-ray structure. The inter-
action between Gαs and AC5 seems to stabilise the position of β7-β8 at the C1/C2 interface,
close to C1’s α1. As C2’s β7-β8 is part of the active site, the position of β7-β8 could be viewed
as a stimulation feature that can be switched on by Gαs or switched off by the absence of Gαs
(free AC5) or by the presence of Gαi1
myr, which stabilises the relocation of the β7-β8 loop even
more (Fig 3).
Gαi1
myr’s interactions with C1 impact AC5’s active site around ATP’s adenine binding
site. While the RMSD of free AC5 and Gαi1
myr:AC5 compared to the initial AC5 structure
(obtained via the Gαs:AC X-ray structure) appear similar for C1, the C2 domain of Gαi1
myr:
AC5 diverges more from the initial structure than free AC5 (Fig 3C). One of the major differ-
ences between the C2 domain of the free AC5 system and the Gαi1
myr:AC5 complex lies on the
membrane side of the proteins. In the case of free AC5, C2’s β4-β5 loop is interacting with the
C1 domain, while in the Gαi1
myr:AC5 complex, the loop does no longer interact with the C1
Fig 4. Rearrangements of AC5’s active site differ between the Gαi1myr:AC5 complex and free AC5 system. (A) Graph of the distances between the
Cα atom of Gly518 (red dot in image B) and the Cα atoms of Asn1202 (green dot in image B) and Asn1205 (yellow dot in image B). The respective
distances in the Gαs:AC(ATPαS) X-ray structure (PDB code 1CJK) of Gly518-Asn1202 (Gly439-Asn1022 in PDB 1CJK) and Gly518-Asn1205
(Gly439-Asn1025 in PDB 1CJK) are 11 Å and 8.5 Å. (B) Detail of AC’s active site of the free AC5 system (purple), the Gαi1myr:AC5 complex (cyan) and the
Gαs:AC(ATPαS) X-ray structure (PDB code 1CJK) in orange. The location of the residues used in image A are assigned according to the Gαi1myr:AC5
structure. In the active site the location of the Mg2+ ion is shown for all three structures as well as the position of ATPαS from the fully activated AC
structure (PDB code 1CJK).
https://doi.org/10.1371/journal.pcbi.1005673.g004
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domain, leading to an unfavourable ATP binding site at the C1/C2 interface (Fig 5A, 5B and
5C). A weakening of the ATP binding site at the C1/C2 interface is also apparent from C1’s
interactions with the C2 domain near the active site region (S8 Fig). Asp1198, for example,
which is important for stabilising ATP’s adenine moiety in the Gαs:AC complex, reorients as
the residue is part of C2’s β4-β5 loop. Due to Asp1198’s change in location, Lys1124, which is
interacting with Asp1198, alters its orientation as well. Lys1124 also influences the stability of
the active site in Gαs:AC as the residue stabilises ATP in a similar fashion as Asp1198 (S8 Fig).
Although C1’s RMSD is low (Fig 3C and S6 Fig), a significant change in conformation can
be observed close to the Gαi1
myr/C1 interface where a kink in α2 occurs, which is less pro-
nounced in free AC5 (Fig 5D). However, overall, the C2 domain seems to be affected most by
the absence of Gαs and the presence of the inhibitory Gα subunit. This observation is in line
Fig 5. Conformational changes on membrane side of AC5 show C2’s loop dissociation, which only occurs in Gαi1myr:AC5. (A) Graph of the
distances between the α2 helix of C1 and the β4-β5 loop of C2 in the Gαi1myr:AC5 structure (see image B). (B) AC5’s membrane side of the free AC5
system (purple), the Gαi1myr:AC5 complex (cyan) and PDB structure 1AZS (yellow) in which the α2 helix of C1 and the β4-β5 loop of C2 are highlighted. In
the Gαi1myr:AC5 complex the location of the residues used in the angle calculation of image D are represented by a green (Ala488), pink (Leu495) and
orange (Phe499) dot. (C) Graph of the distances between the α2 helix of C1 and the β4-β5 loop in the AC5 system (see image B). (D) Angle between three
helical turns, including Cα atoms of Ala488, Leu495 and Phe499, in which the kinking of the α2 helix of C1 takes place (see image B).
https://doi.org/10.1371/journal.pcbi.1005673.g005
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with the hypothesis that Gαi1
myr is able to constrain C1’s conformation via its tight interactions
with this domain, leading to a perturbation and destabilisation of the active site at the C1/C2
interface (Fig 5 and S7 Fig). This change of the C1/C2 interface prevents the catalytic domains
to sample the conformation in which ATP could be positioned in the active site due to a
decrease in distance between C2’s α4 helix and C1’s β2-β3 loop and a relocation of C2’s β4-β5
and β7-β8 loops (Figs 3, 4 and 5), which play important roles in the construction of the active
site.
Presence of Gαi1
myr induces closure of Gαs’s interaction site on AC5’s C2 domain.
Besides the direct conformational changes in AC5’s active site, another mechanism that could
Fig 6. Conformational changes around the Gαs binding site on C2 show distinct events of closure in Gαi1myr:AC5. (A) Graph of the distance
between the α2 and the α3 helix of C2 including Cα atoms of Asn1091 and Phe1171, of free AC5 and Gαi1myr:AC5. A detailed representation of the Gαs
binding site is shown in image C. (B) the Gαs binding site of the free AC5 system (purple), the Gαi1myr:AC5 complex (cyan) and PDB structure 1AZS
(yellow) in which the Gαs subunit is also shown. (C) Detail of the Gαs binding site of Gαi1myr:AC5 in which residues that are involved in the closing of the
binding site are shown.
https://doi.org/10.1371/journal.pcbi.1005673.g006
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induce inhibition is decreasing the probability of Gαs binding to the C2 domain. In free AC5
as well as in Gαi1
myr:AC5, the Gαs site seems to become less favourable for Gαs binding since
the distance between C2’s α2 and α3, α2-α3, is significantly decreased with respect to the X-
ray structure of the Gαs:AC complex (Fig 6A and 6B). In the free AC5 system α2-α3 changes
from around 16 Å (initial distance between the Cα carbons of Asn221 and Phe1171) to an
average distance of * 11 Å (Fig 6A and 6B). In the Gαi1myr:AC5 simulations, the distance
between the two residues can decrease even more severely to a distance of * 7 Å (Fig 6A and
6B), leading to a closed Gαs binding site conformation. Important residues that stabilise this
closed conformation of the Gαs binding site in Gαi1
myr:AC5 are AC5’s: Glu1083, Leu1088,
Ala1090, Phe1171, Asn1172 and Asn1173 (Fig 6D). Hence, due to the interaction with
Gαi1
myr, the catalytic domains of AC5 appear to deactivate AC5’s catalytic ability via deforma-
tion of the active site as well as by sampling closed Gαs binding site conformations.
Possible mechanism of Gαi1myr inhibition
The simulation of Gαi1
myr:AC5 in comparison with the free AC5 trajectory and the Gαs:AC X-
ray structure demonstrate that the first step in decreasing AC5’s activity in the apo form is the
relocation of the β7-β8 loop (Fig 7, step one). In fact, the β7-β8 loop seems to have an impor-
tant role for the stimulatory response since the presence of Gαs leads to the stabilisation of the
Fig 7. Graphical representation of proposed AC5 inhibition mechanism by Gαi1myr with the upper row showing the cytosolic side of AC5 and
the bottom row depicting AC5 from the membrane side. The myristoyl moiety bound to Gαi1 is shown via a purple line on the subunit. The change that
takes place in step (1) compared to the initially stimulated AC5 conformation, is the relocation of the C2 β7-β8 loop away from its active position. This
alteration takes place near AC5’s active site (red star), which is also affected by this event. Conformational change (2) involves the loss of interaction
between C1’s α2 and the C2 β4-β5 loop, weakening the active site. The final rearrangement (3) includes the closer packing of C2’s Gαs interaction site,
which appears to result in a less favourable C2 conformation for the interaction with Gαs.
https://doi.org/10.1371/journal.pcbi.1005673.g007
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loop, forming ATP’s binding site (Fig 7, starting conformation of AC in left panel) [23]. This
loop conformation is lost as soon as Gαs is absent, as observed for both free AC5 and Gαi1
myr:
AC5. In step two of Fig 7 the Gαi1
myr:AC5 complex undergoes a rearrangement in the C2
domain (absent in free AC5), which leads to a further perturbation of AC5’s active site. The
classical molecular dynamics simulations also show that in the presence of Gαi1
myr, there
appears to be a decrease in probability for Gαs association (Fig 7, step 3 and Fig 6). Hence,
through these rearrangements Gαi1
myr could deactivate apo AC5 as well as decrease the proba-
bility of reactivation via Gαs.
Conclusion
The results of this study suggest that Gαi1
myr deactivates the apo form of adenylyl cyclase type
5 via constraining C1’s active site region. Inhibition and stimulation of AC5 appear to follow
different pathways. While Gαs binds between the helices of C2, increasing the stability of the
C1:C2 dimer, Gαi1
myr is able to clamp the helices of the C1 domain, promoting an inactive
conformation of AC5’s catalytic domains and a possible decrease in affinity for Gαs on the C2
domain. Structurally, Gαs and non-myristoylated Gαi1 are very similar, however, when myris-
toylation has taken place on the N-terminus of Gαi1, the conformation of the subunit changes
drastically, leading to a structure that differentiates itself from the active Gαs subunit and
enables the protein to function in an inhibitory fashion as is shown via the presented classical
MD simulations. Hence, in line with experimental studies, myristoylation appears to be crucial
for Gi’s function and demonstrates how important even relatively small changes to a protein
structure can be for its function.
Supporting information
S1 Fig. Sequence alignment of human Gαi1, Gαi2, Gαi3, which shows a 84% sequence iden-
tity between the subunits.
(TIF)
S2 Fig. Gαi1
myr interacting with AC type 5 shows a different type of interaction mode with
AC5 than Gαs. (A) Representation of the docked Gαi1
myr:AC5 complex of Rattus norvegicus
with the location of Gαs depicted as well to show the difference in association between the two
Gα subunits. Gαs is depicted in gray, Gαi1
myr in cyan, the C1 domain in blue and the C2
domain in red. The location of the GTP molecules in both Gα subunits is represented by the
red pentagons. (B) View from the cytosolic side on the docked Gαi1
myr:AC5 complex, showing
the position of the ATP molecule in the catalytic C1 domain in green. The colour scheme is
the same as in image A. (C, D) The difference in active AC conformation is shown, depending
on AC’s interaction partners (e.g. analog of the substrate ATP, the inhibitor Ca2+, substrate
free). The alignment of the initial Gαi1
myr:AC5 complex with three AC:Gαs complexes demon-
strates that the initial apo AC5 structure used in this study is different from the fully active AC
conformation (yellow) to which ATPαS is bound. The yellow structure is a complex of Gαs:AC
with ATPαS and forskolin (PDB code 1CJK). ATPαS is depicted in transparent yellow in
which oxygen atoms are red, phosphor is tan and carbon is cyan. This structure is an active
conformation of the AC catalytic domain. The blue (PDB code 3MAA) [44] is suggested to be
an inactive Gαs:AC complex and interacts with methylpiperazinoforskolin (FKP) together
with ATPαS and a Ca2+ ion. The red structure (PDB code 1AZS), used as main template for
the AC5 conformation in this study, is an Gαs:AC complex that only interacts with FKP in the
catalytic domain and is more similar to the 3MAA structure than the fully active 1CJK struc-
ture around AC’s active site. (E) Alignment of the Gαi1
non:RGS4 complex (PDB code 1AGR)
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and Gαi1
myr. In case of the non-myristoylated Gαi1:RGS4 structure (Gαi1
non:RGS4), Gαi1
non is
shown in red and RGS4 is shown in orange. The myristoylated Gαi1 is depicted in cyan. The
location of Thr182, Glu207 and Lys210 are shown for both complexes as these residues are
important for the interaction between RGS4 and Gαi1 [45]. The Gαi1
non:RGS4 residues are
labeled in red and the Gαi1
myr residues are labeled in blue.
(TIF)
S3 Fig. View of the docked Gαi1
myr:AC5 complex from the cytosolic side. The Gαi1
myr sub-
unit is depicted in cyan, while the C1 domain is represented in blue and the C2 domain is
shown in red. The location of the Gαs structure is described by the grey star and the GTP mol-
ecule is represented by the red pentagon.
(TIF)
S4 Fig. Distances between the Mg2+ ion and residues in the active site of AC. (A) Distances
between the Mg2+ ion and residues in the active site of the Gαi1
myr:AC5 system. (B) Distances
between the Mg2+ ion and residues in the active site of the free AC5 system.
(TIF)
S5 Fig. Mg2+ ion in the active site of AC of the Gαi1
myr:AC5 complex is located in the same
interaction position as in ATPαS or pyrophosphate bound X-ray structures of Gαs:AC
complexes. (A) Alignment of the Gαi1
myr:AC5 complex (cyan), the free AC5 system (purple)
and catalytically active AC (PDB code 1CJK) in orange, which is interacting with ATPαS,
showing the active site of AC at the C1/C2 interface. The residue names are following the Rat-
tus norvegicus numbering for AC5. (B) Alignment of the Gαi1
myr:AC5 complex (cyan), the AC
system (purple) and AC associated to pyrophosphate, PPi, (PDB code 3C15) in blue showing
the active site of AC at the C1/C2 interface. The residue names are following the Rattus norve-
gicus numbering for AC5.
(TIF)
S6 Fig. Root-mean-square deviations of the backbone of the C1:C2 dimer. Additionally also
the RMSD of the Gαi1
myr subunit in the Gαi1
myr:AC5 is shown, together with the RMSD of the
combination of Gαi1
myr and the C1 domain. In the RMSD calculation the residues between
463 to 644 were taken into account for the C1 domain, residues between 1065 to 1135 and
1145 to 1257 were used for the C2 domain and residues 34 to 334 were included for the
Gαi1
myr subunit.
(TIF)
S7 Fig. Graph of the distances between the Mg2+ ion in the active site of Gαi1
myr. Distances
are shown between the Mg2+ ion and its environment, including GTP and the Gαi1
myr residues
that are coordinating to the Mg2+ ion: Ser47, Asp200.
(TIF)
S8 Fig. Changes in the location of important residues in the active site of AC. (A) Detail of
the active site of AC in the Gαi1
myr:AC5 complex, showing the residues that are used in the dis-
tance calculations for image b and d. Additionally, the position of the Mg2+ ion is shown in
pink. (B) Graph of the distances in the Gαi1
myr:AC5 system between the Cα carbon of Asp475,
which is positioned close to the ATP binding site, and other important residues for ATP con-
version: Lys1124, Asp1198, Arg1209 and Lys1245. (C) Detail of the active site of AC in the
Gαs:AC complex to which ATPαS is bound (PDB code 1CJK), showing the equivalent residues
of the residues in AC5 that are used in the distance calculations for image B and D. (D) Graph
of the distances in the AC system between the Cα carbon of Asp475, which is positioned close
to the ATP binding site, and other important residues for ATP conversion: Lys1124, Asp1198,
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Arg1209 and Lys1245.
(TIF)
S1 Appendix. Supporting results and discussion.
(PDF)
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